| Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab P Yousefpour, F Atyabi, E Vasheghani-Farahani, AAM Movahedi, ... International journal of nanomedicine, 1977-1990, 2011 | 206 | 2011 |
| Polyanionic carbohydrate doxorubicin–dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluations P Yousefpour, F Atyabi, EV Farahani, R Sakhtianchi, R Dinarvand International journal of nanomedicine, 1487-1496, 2011 | 103 | 2011 |
| Co‐opting biology to deliver drugs P Yousefpour, A Chilkoti Biotechnology and bioengineering 111 (9), 1699-1716, 2014 | 91 | 2014 |
| Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery S Banskota, P Yousefpour, N Kirmani, X Li, A Chilkoti Biomaterials 192, 475-485, 2019 | 83 | 2019 |
| Recombinant synthesis of hybrid lipid–peptide polymer fusions that self‐assemble and encapsulate hydrophobic drugs KM Luginbuhl, D Mozhdehi, M Dzuricky, P Yousefpour, FC Huang, ... Angewandte Chemie International Edition 56 (45), 13979-13984, 2017 | 67 | 2017 |
| Conjugate of Doxorubicin to Albumin‐Binding Peptide Outperforms Aldoxorubicin P Yousefpour, L Ahn, J Tewksbury, S Saha, SA Costa, JJ Bellucci, X Li, ... Small 15 (12), 1804452, 2019 | 50 | 2019 |
| Cell‐based biohybrid drug delivery systems: The best of the synthetic and natural worlds S Banskota*, P Yousefpour*, A Chilkoti Macromolecular Bioscience 17 (1), 1600361, 2017 | 50 | 2017 |
| Genetically encoding albumin binding into chemotherapeutic-loaded polypeptide nanoparticles enhances their antitumor efficacy P Yousefpour, JR McDaniel, V Prasad, L Ahn, X Li, R Subrahmanyan, ... Nano letters 18 (12), 7784-7793, 2018 | 43 | 2018 |
| Genetically encoded stealth nanoparticles of a Zwitterionic polypeptide-paclitaxel conjugate have a wider therapeutic window than Abraxane in multiple tumor models S Banskota, S Saha, J Bhattacharya, N Kirmani, P Yousefpour, ... Nano letters 20 (4), 2396-2409, 2020 | 41 | 2020 |
| Targeted modulation of immune cells and tissues using engineered biomaterials P Yousefpour, K Ni, DJ Irvine Nature reviews bioengineering 1 (2), 107-124, 2023 | 39 | 2023 |
| Preparation and comparison of chitosan nanoparticles with different degrees of glutathione thiolation P Yousefpour, F Atyabi, R Dinarvand, E Vasheghani-Farahani DARU: Journal of Faculty of Pharmacy, Tehran University of Medical Sciences …, 2011 | 32 | 2011 |
| Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity L Ma, A Hostetler, DM Morgan, L Maiorino, I Sulkaj, CA Whittaker, ... Cell 186 (15), 3148-3165. e20, 2023 | 26 | 2023 |
| Tumor Subtype Determines Therapeutic Response to Chimeric Polypeptide Nanoparticle–based Chemotherapy in Pten-deleted Mouse Models of Sarcoma RD Dodd, A Scherer, W Huang, GR McGivney, WR Gutierrez, EA Laverty, ... Clinical cancer research 26 (18), 5036-5047, 2020 | 7 | 2020 |
| Heuristics for the optimal presentation of bioactive peptides on polypeptide micelles J Wang, S Saha, JL Schaal, P Yousefpour, X Li, A Chilkoti Nano Letters 19 (11), 7977-7987, 2019 | 6 | 2019 |
| Eradication of tumors with pre-existing antigenic heterogeneity by vaccine-mediated co-engagement of CAR T and endogenous T-cells L Ma, DM Morgan, I Sulkaj, P Yousefpour, CA Whittaker, W Abraham, N Li, ... bioRxiv, 2022.10. 05.511036, 2022 | 5 | 2022 |
| Recombinant Fusion of Glucagon‐Like Peptide‐1 and an Albumin Binding Domain Provides Glycemic Control for a Week in Diabetic Mice P Yousefpour, A Varanko, R Subrahmanyan, A Chilkoti Advanced Therapeutics 3 (10), 2000073, 2020 | 4 | 2020 |
| Optimization of an alum-anchored clinical HIV vaccine candidate KA Rodrigues, CA Cottrell, JM Steichen, B Groschel, W Abraham, H Suh, ... npj Vaccines 8 (1), 117, 2023 | 1 | 2023 |
| Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum] P Yousefpour, F Atyabi, E Vasheghani-Farahani, AAM Movahedi, ... International Journal of Nanomedicine 17, 5047-5048, 2022 | 1 | 2022 |
| Directed evolution-based discovery of ligands for in vivo restimulation of CAR-T cells L Ma, R Ramasubramanian, N Mehta, B Cossette, D Morgan, I Sukaj, ... bioRxiv, 2024.04. 16.589780, 2024 | | 2024 |
| Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same A Chilkoti, S Banskota, P Yousefpour, J Bhattacharyya US Patent 11,458,205, 2022 | | 2022 |
Ashutosh ChilkotiDuke UniversityVerified email at duke.edu
